SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy With Distinct Clinicopathological Characteristics

Ghassan Al-Shbool1, Hari Krishnan Nair1

  • 1Hematology and Medical Oncology, Saint Louis University School of Medicine, St Louis, USA.

Cureus
|November 28, 2022
PubMed
Summary

Switch/sucrose non-fermentable-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4-deficient undifferentiated tumors (SMARCA4-dUT) are aggressive, rare malignancies. This study presents two cases, offering insights into their behavior and management.